ursodeoxycholic acid has been researched along with Alloxan Diabetes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Salami, H; Al-Sallami, H; Arfuso, F; Goločorbin-Kon, S; Kovacevic, B; Luna, G; Mikov, M; Mooranian, A; Stojanovic, G; Zamani, N | 1 |
| Al-Salami, H; Goločorbin-Kon, S; Ionescu, CM; Kovačević, B; Luna, G; Mikov, M; Mooranian, A; Takechi, R; Zamani, N | 1 |
| Abdel-Ghaffar, A; Ahmed, EK; Ghanem, HM; Hassanin, OA; Mohamed, RG | 1 |
| Al-Salami, H; Al-Sallami, H; Arfuso, F; Goločorbin-Kon, S; Kovacevic, B; Mikov, M; Mooranian, A; Takechi, R; Zamani, N | 1 |
| An, SH; Chung, J; Kang, SW; Kwon, K | 1 |
| Al-Salami, H; Elahy, M; Lam, V; Mamo, JC; Mooranian, A; Negrulj, R; Takechi, R | 1 |
| Choi, JA; Chung, YR; Koh, JY; Yoon, YH | 1 |
| Arellano, A; Bautista, R; Coronel, I; Escalante, B; Franco, M; Osorio, H | 1 |
| Buko, VU; Lukivskaya, O; Patsenker, E | 1 |
| Hüdepohl, JM; Zielke, R | 1 |
10 other study(ies) available for ursodeoxycholic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Combinations; Drug Compounding; Excipients; Insulin-Secreting Cells; Mice, Inbred BALB C; Particle Size; Probucol; Tissue Distribution; Ursodeoxycholic Acid | 2019 |
Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
Topics: Acrylates; Animals; Bile Acids and Salts; Blood Glucose; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Feces; Insulin; Lithocholic Acid; Mice; Nanoconjugates; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid suppresses the formation of fructose/streptozotocin-induced diabetic cataract in rats.
Topics: Animals; Antioxidants; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Fructose; Glutathione; Hyperglycemia; Insulin; Lens, Crystalline; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Ursodeoxycholic Acid | 2018 |
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Insulin-Secreting Cells; Intestinal Mucosa; Liver; Mice; Mice, Inbred BALB C; Nanocapsules; Probucol; Ursodeoxycholic Acid | 2018 |
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endoplasmic Reticulum Stress; Human Umbilical Vein Endothelial Cells; Mice; NF-kappa B; Oxidative Stress; Plaque, Atherosclerotic; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction; Ursodeoxycholic Acid | 2016 |
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance.
Topics: Angiotensin II; Animals; Capsules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Hypertension; Insulin Resistance; Male; Mice; Time Factors; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.
Topics: Animals; Blood-Retinal Barrier; Cell Line; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endoplasmic Reticulum Stress; Humans; Mice; Pericytes; Retina; Unfolded Protein Response; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Kidney; Male; Oxidative Stress; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Ursodeoxycholic Acid | 2012 |
Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Liver; Luminescent Measurements; Male; Malondialdehyde; Mitochondria; NADH Dehydrogenase; Oxidative Stress; Oxygen Consumption; Rats; Rats, Wistar; Succinate Dehydrogenase; Ursodeoxycholic Acid | 2007 |
[Formation and modification of bile lipids].
Topics: Animals; Bile; Cholelithiasis; Cholesterol; Clofibrate; Contraceptives, Oral, Hormonal; Diabetes Mellitus, Experimental; Obesity; Phospholipids; Rats; Ursodeoxycholic Acid | 1983 |